Literature DB >> 3319303

Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits.

D Abramowicz1, M Goldman, C Bruyns, P Lambert, Y Thoua, C Toussaint.   

Abstract

Balb/c neonates injected with semi-allogeneic (A/J x Balb/c) F1 hybrid spleen cells develop an autoimmune disease associated with an immune-complex glomerulonephritis. The successful induction and maintenance of B cell chimerism is required for the occurrence of autoimmunity. The percentage of chimeric mice displaying autoimmune features increases in parallel with the number of cells injected at birth. T cell depleted inocula although readily inducing B cell chimerism were found unable to induce hypergammaglobulinaemia, circulating immune complexes and glomerulonephritis. IgG1 is the most and IgG3 the least represented IgG isotype among the immunoglobulins deposited in the glomeruli. Immunoglobulins bearing donor (A/J) allotype are detected in the glomeruli of six out of 11 chimeric mice. Rheumatoid factor activity is significantly concentrated within the immunoglobulins eluted from the kidneys, whereas anti-DNA activity is not.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319303      PMCID: PMC1542205     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis.

Authors:  A G Rolink; H Gleichmann; E Gleichmann
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

3.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

4.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Studies on the thymic dependence of the immunoglobulin classes of the mouse (38570).

Authors:  A D Bankhurst; P H Lambert; P A Miescher
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

6.  Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice.

Authors:  M Goldman; H M Feng; H Engers; A Hochman; J Louis; P H Lambert
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

7.  Autoreactive T cells in mercury-induced autoimmune disease: in vitro demonstration.

Authors:  L Pelletier; R Pasquier; F Hirsch; C Sapin; P Druet
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

8.  Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation.

Authors:  S Luzuy; J Merino; H Engers; S Izui; P H Lambert
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes.

Authors:  S Izui; P H Lambert; G J Fournié; H Türler; P A Miescher
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  1 in total

1.  Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice.

Authors:  M Goldman; D Abramowicz; P Lambert; P Vandervorst; C Bruyns; C Toussaint
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.